Preclinical development of an anti-CD30/anti-CD16A bispecific tetravalent TandAb antibody for the treatment of Hodgkin lymphoma.
Stefan Knackmuss
Employment or Leadership Position - Affimed Therapeutics
Uwe Reusch
Employment or Leadership Position - Affimed Therapeutics
Carmen Burkhardt
Employment or Leadership Position - Affimed Therapeutics
Ivica Fucek
Employment or Leadership Position - Affimed Therapeutics
Fabrice Le Gall
No relevant relationships to disclose
Hans-Gerd Pauels
Consultant or Advisory Role - Pauels Consulting
Melvyn Little
Employment or Leadership Position - Affimed Therapeutics
Consultant or Advisory Role - Affimed Therapeutics
Stock Ownership - Affimed Therapeutics
Eugene Zhukovsky
Employment or Leadership Position - Affimed Therapeutics
Stock Ownership - Affimed Therapeutics